Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Diseases

NCT05629065 2025-08-28

(PATH-SIC)

Phase NA Active not recruiting

800 enrolled

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Urogenital Neoplasms

NCT06384417 2025-08-08

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2

Phase NA Active not recruiting

32 enrolled

BreastDermatologicGastrointestinalHead & NeckThoracic

Breast Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT05887245 2025-06-27

Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy

Active not recruiting

200 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT04811846 2024-12-09

CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood

Phase NA Active not recruiting

40 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplastic Cells, Circulating, Neoplasms, Urogenital Neoplasms

Clinical Trials

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

IMPACT

An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

CISTO

(PATH-SIC)

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2

Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy

CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood